Status:
COMPLETED
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Dyslipidemia/Glucose Metabolism Disorder
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To demonstrate in patients with T2DM and dyslipidemia not appropriately controlled with a statin and receiving metformin, the superiority of a fixed combination of fenofibrate and metformin vs metform...
Eligibility Criteria
Inclusion
- Inclusion Criteria Patient with Type 2 Diabetes treated with stable dose of metformin and with dyslipidemia not appropriately controlled with a statin treatment.
- Exclusion Criteria Type 1 diabetes.
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
482 Patients enrolled
Trial Details
Trial ID
NCT00362323
Start Date
October 1 2006
End Date
March 1 2009
Last Update
April 16 2010
Active Locations (70)
Enter a location and click search to find clinical trials sorted by distance.
1
C LF23-0121 06 01 Site107
Brno, Czechia
2
C LF23-0121 06 01 Site108
Holešov, Czechia
3
C LF23-0121 06 01 Site101
Karlovy Vary, Czechia
4
C LF23-0121 06 01 Site106
Olomouc, Czechia